Invitae Corporation
- UEI
- QCUXDXHHWH29
- CAGE
- 5XDW6
- Primary NAICS
- 621511 Medical Laboratories
- SAM.gov registration
- Expired
Company facts
- FY2025 rankings
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Website
- invitae.com
- Founded
- 2010
- Employees
- 1K-5K
- Estimated annual revenue
- $250M-$500M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | -$98,488 |
| FY2025 | $99,099 |
| FY2024 | $203,569 |
| FY2023 | $295,794 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| University Of California Irvine | U01HG011745 | $541,390 | |
| University Of California Irvine | U01HG011745 | $990,284 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Fulgent Genetics, Inc. | El Monte, CA | 621511 Medical Laboratories |
| Genedx, LLC | Gaithersburg, MD | 621511 Medical Laboratories |
| Clear Labs Inc. | San Carlos, CA | 621511 Medical Laboratories |
| Athena Diagnostics, Inc. | Marlborough, MA | 621511 Medical Laboratories |
| Medgenome Inc. | Foster City, CA | 621511 Medical Laboratories |
About the company
Invitae Corporation is a for-profit genetic information and diagnostic testing company headquartered in San Francisco, California, specializing in advanced genetic testing services for medical research and healthcare. Registered in SAM.gov since 2010, the company provides comprehensive genetic testing capabilities to multiple federal agencies, including genetic diagnostics, whole genome sequencing, variant analysis, and clinical testing services. Invitae has established itself as a key provider of genetic testing solutions to federal healthcare systems, particularly the Department of Veterans Affairs (VA), National Institutes of Health (NIH), and Department of Defense medical commands.
Through federal contract awards, Invitae has primarily delivered genetic testing services across various VA Veterans Integrated Service Networks (VISNs), providing reference laboratory testing, genetic testing kits, and genomic medicine support. These contracts, typically structured as firm fixed-price purchase orders ranging from $4,750 to $641,360, have focused on supporting precision medicine initiatives, diagnostic testing, and genomic healthcare programs. The company has performed next-generation sequencing, variant confirmation analysis, and clinical diagnostic services for multiple federal agencies, including the VA, NIH's National Heart, Lung and Blood Institute, National Human Genome Research Institute, and the Defense Health Agency. None of these contract awards utilized set-aside designations, indicating open competition.
Regarding federal grant sub-awards, Invitae has collaborated with prominent research institutions like the University of California Irvine and The Broad Institute to support genomic research initiatives. The company has contributed to critical research programs such as the Pediatric Mendelian Genomics Research Center and the ClinGen Resource program. Specific contributions have included whole genome sequencing, long-read sequencing, functional modeling, variant prioritization, and hosting patient registries like GenomeConnect. Invitae has leveraged its technological platforms to support data sharing, variant curation, and research aimed at understanding genetic variations and their clinical implications.
Invitae holds a notable federal contract Indefinite Delivery/Indefinite Quantity (IDV) with the Department of the Army Medical Command, specifically a multiple-award blanket purchase agreement valued at $950,000. This IDV covers genetic testing services for Tripler Army Medical Center in Hawaii, requiring capabilities such as whole genome sequencing, deletion/duplication analysis, and variant confirmation using next-generation sequencing technology. The agreement enables the Military Health System to access advanced genetic testing capabilities, supporting diagnostic and research needs for service members and beneficiaries in the Hawaiian region.
SBA capabilities narrative
Invitae is a CLIA lab providing comprehensive genetic testing services using next generation sequencing. Our goal is to make high-quality genetic testing affordable and accessible.
Quick answers
Is Invitae Corporation registered in SAM.gov?
Invitae Corporation's SAM.gov registration expired on October 2, 2025.
How much has Invitae Corporation received in federal contracts?
Federal contracts obligated $99,099 to Invitae Corporation in fiscal year 2025 and $499,974 in fiscal years 2023 through 2027.
How does Invitae Corporation rank among federal contractors?
Invitae Corporation ranked #35 in PSC 6632 in FY2025.
What is Invitae Corporation's most recent federal award?
Invitae Corporation's most recent federal contract award is Ratification (36C26024P1215), from Veterans Integrated Service Network 20 (VHA), on September 18, 2024.
On GovTribe
See Invitae Corporation's full federal record
- Federal contract awards
- IDV awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors